| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | CHRM3 antibody|Muscarinic acetylcholine receptor M3 antibody |
| Assay Time | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Serum, Plasma, Cell Culture Supernatant, cell or tissue lysate, Other liquid samples |
| Sensitivity | |
| Species | |
| Storage | |
| Target |
Background
human Anti-M3 AChR (Anti-M3 Acetylcholine Receptor Antibody) is a molecular target commonly studied in biomedical research. Autoantibodies are immune proteins that recognize self-antigens, and their presence can reflect changes in immune tolerance or chronic antigen exposure.
Biological role and mechanism
The biological role of Anti-M3 AChR is typically understood in terms of its molecular category and interaction network. Depending on the model system, it may participate in cell–cell communication, intracellular signaling, enzymatic processing, or regulation of gene expression programs. Mechanistic interpretation is often strengthened by considering upstream regulators and downstream readouts rather than relying on a single marker.
Expression and abundance of Anti-M3 AChR can vary by tissue, cell type, and physiological state. In many systems, levels are influenced by factors such as developmental stage, immune activation, metabolic status, and cellular stress. Because sample matrix and pre-analytical handling can affect measured concentrations, interpretation is typically strongest when experiments keep collection and processing consistent across groups.
Nomenclature and related terms
Anti-M3 AChR (Anti-M3 Acetylcholine Receptor Antibody) may also be referenced as CHRM3 antibody and Muscarinic acetylcholine receptor M3 antibody in the literature or in databases. When comparing results across studies, confirm that the reported analyte refers to the same molecule, species context, and molecular form (e.g., precursor vs mature protein, or soluble vs membrane-associated forms).
Why it matters in research
- Understanding how Anti-M3 AChR relates to signal transduction, tissue homeostasis, stress responses, and disease-model biology in biomedical research.
- Interpreting shifts in Anti-M3 AChR levels alongside other pathway components or complementary markers.
- Connecting molecular changes to phenotypes such as inflammation, remodeling, metabolism shifts, or cell-state transitions (context-dependent).
Molecular forms and interpretation
For some targets, isoforms, proteolytic processing, or post-translational modifications (such as phosphorylation or glycosylation) can influence function and apparent abundance. If multiple molecular forms are expected in your model, align interpretation with the form most relevant to the biological question.
Disease and translational relevance
Anti-M3 AChR has been investigated across diverse physiological and disease contexts, and changes in its abundance have been reported in areas aligned with biomedical studies. These associations are interpreted as research findings rather than diagnostic or therapeutic claims, and they should be evaluated alongside model-specific covariates and study design.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Comparison of anti-desmoglein antibodies titres and anti-M3 muscarinic acetylcholine receptor antibody titres as biomarker for potential pemphigus between subjects who are occupationally exposed and not exposed to pesticides
IF: 3.4 Journal: Indian Journal of Dermatology, Venereology and Leprology Author: Departments of Dermatology, Venereology and Leprology, Postgraduate Institute of Medical Education and Research, Chandigarh Cited Date: 2025-06-20
Clinical and immunological predictors of post-rituximab paradoxical pemphigus flare: A prospective cohort study
IF: 2.9 Journal: Indian Journal of Dermatology, Venereology and Leprology Author: Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India. Cited Date: 2024-04-26